Active Genetic Tech Raises $11.8 Million
Applied Genetic Technologies Corp., an Alachua, Fla.-based drug developer, has raised $11.8 million in new VC funding. InterWest Partners led the round, and was joined by fellow return backers Intersouth Partners and MedImmune Ventures. The company had previously raised nearly $34 million.
4 May 2009•3 mins read
